RIO DE JANEIRO, BRAZIL - Brazilian federal prosecutors have opened an investigation into a contract worth R$1.6 billion (US$320 million) for 20 million doses of a Covid-19 vaccine made by India's Bharat Biotech, according to a document seen by Reuters on Tuesday, June 22.
The prosecutor-general's office (PGR) cited comparatively high prices, speedy talks and pending regulatory approvals as red flags for the Bharat contract signed in February, before similar deals with Pfizer Inc and Johnson & Johnson.
Bharat did not immediately respond to a request for comment outside of business hours in India . . .